BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The eagerly anticipated mRNA-Based Therapeutics Summit Europe 
 returns to Berlin this January for the third year as Europe's largest and
  most important gathering of mRNA experts.\n\nShowcasing exclusive new da
 ta from the trailblazers and thought leaders in the field\, join 250+ ind
 ustry specialists including the likes of the MHRA\, EMA\, BioNTech\, Cure
 Vac\, Ziphius Vaccines\, Moderna and more across 3 days to uncover ground
 breaking discovery\, pre-clinical and clinical insights in mRNA therapeut
 ic and vaccine development to fast-track R and D and pipeline expansions.
 \n\nURLs:Tickets:&nbsp\;https://go.evvnt.com/1951095-2?pid=185Brochure:&n
 bsp\;https://go.evvnt.com/1951095-3?pid=185\n\nPrices:Conference + Focus 
 Day OR Workshop Day - Drug Developer Pricing: EUR 4446.00\,Conference Onl
 y - Drug Developer Pricing: EUR 2799.00\,Conference + Focus Day OR Worksh
 op Day - Small Biotech Pricing: EUR 4246.00\,Conference Only - Small Biot
 ech Pricing: EUR 2799.00\,Conference + Focus Day OR Workshop Day - Academ
 ic Pricing: EUR 3896.00\,Conference Only - Academic Pricing: EUR 2399.00\
 ,Conference + Focus Day OR Workshop Day - Service Provider Pricing: EUR 5
 446.00\,Conference Only - Service Provider Pricing: EUR 3499.00\n\nSpeake
 rs:&nbsp\;Ajan Reginald Chief Executive Officer &nbsp\;Roquefort Therapeu
 tics plc\, Alexander Zehnder CEO &nbsp\;CureVac\, Amit Benazraf Business 
 Development Lead &nbsp\;Mana Bio\, Anette Sommer Senior Director\, Emergi
 ng Science and Innovation\, Lead Oncology Europe &nbsp\;Pfizer\, Arun Kum
 ar Preclinical Vaccines Development Lead &nbsp\;CEPI\, Carsten Rudolph CE
 O &nbsp\;Ethris\, Chris Cardon CEO &nbsp\;Ziphius Vaccines\, Claudia Lind
 emann Director - Non-Clinical Safety &nbsp\;BioNTech SE\, Covadonga Paned
 a Chief Operating Officer &nbsp\;Altamira Therapeutics\, Daniel Tondera H
 ead of Biology &nbsp\;Pantherna Therapeutics\, Duccio Medini R3 Program D
 irector &nbsp\;Wellcome Leap\, Estelle Beguin Director - Technology Resea
 rch &nbsp\;Ethris\, Fernando Ulloa Montoya Head - Data and Computational 
 Science &nbsp\;mRNA Center of Excellence\, Sanofi\, Gad Berdugo Managing 
 Partner\; Strategic Advisor &nbsp\;Explorium Capital LLC\; Nutcracker The
 rapeutics\, Jenny van Asbeck CEO &nbsp\;Mercurna\, Jens Demand Director -
  Product Life Cycle &nbsp\;PATH\, Jerry Zhang Vice President - Formulatio
 n Research and Development &nbsp\;Abogen Biosciences\, Ka-Wai Wan Senior 
 Pharmaceutical Assessor &nbsp\;Medicines and Healthcare Products Regulato
 ry Agency (MHRA)\, Marco Cavaleri Head of Biological Health Threats and V
 accines Strategy &nbsp\;European Medicines Agency\, Maren von Fritschen H
 ead - Regulatory Policy Europe &nbsp\;Moderna\, Martin Friede Initiative 
 for Vaccine Research Coordinator &nbsp\;World Health Organization - WHO\,
  Martin Friede Initiative for Vaccine Research Coordinator &nbsp\;World H
 ealth Organization - WHO\, Myriam Mendila Chief Development Officer &nbsp
 \;CureVac\, Rajesh Krishnan Director of Formulations &nbsp\;Providence Th
 erapeutics Inc.\, Sam Deutsch Executive Vice President\, Research and Ear
 ly Development &nbsp\;Nutcracker Therapeutics\, &nbsp\;Sanjay Singh CEO &
 nbsp\;Gennova Biopharmaceuticals\, Simone Blayer Global Head - CMC &nbsp\
 ;PATH\, Sonia Golombek Senior Research and Development Manager &nbsp\;Ela
 strin Therapeutics\, Sven Jager Computational Science Manager &nbsp\;Sano
 fi\, Swarnendu Kaviraj Associate Director - R and D &nbsp\;Gennova Biopha
 rmaceuticals\, Thomas Langenickel Chief Medical Officer &nbsp\;Ethris Gmb
 H\, Tim Sparey Managing Director &nbsp\;VaxEquity\, Wade Davis VP - Compu
 tational Science &nbsp\;Moderna\, Yaniv Erlich CEO &nbsp\;Eleven Therapeu
 tics\, Ana Rebane Professor &nbsp\;University of Tartu\, Camilla Foged Pr
 ofessor &nbsp\;University of Copenhagen\, Chantal Pichon Professor and He
 ad of Research unit &nbsp\;University of Orleans\, Lorenzo Franceschini C
 o-Founder / mRNA Development and Production Lead &nbsp\;Vrije University 
 Brussels\, Mark Dickman Professor &nbsp\;University of Sheffield\, Nawaz 
 Muhammad Senior Scientist &nbsp\;University of Salzburg\, Simone Spuler P
 rofessor &nbsp\;Charité Universitätsmedizin Berlin\, Tim Beissert Head Im
 mune and Gene Therapy Development &nbsp\;TRON\, Ioana Panait Research Ana
 lyst &nbsp\;Beacon Targeted Therapies\, Matthias Lubbert Principle Engine
 er - Process &nbsp\;KNAUER Wissenschaftliche Geräte GmbH\, May Guo Chief 
 Commercial Officer &nbsp\;Areterna\n\nDate and Time:&nbsp\;23rd January 2
 024 at 9:00 am to 25th January 2024 at 5:00 pm\n
DTEND:20240125T170000
DTSTAMP:20260512T223119Z
DTSTART:20240123T090000
LOCATION:Mercure Hotel MOA Berlin\, 41 \, Stephanstraße\, Berlin\, \, 1055
 9\,
SEQUENCE:0
SUMMARY:The eagerly anticipated mRNA-Based Therapeutics Summit Europe retu
 rns to Berlin this January for the third year as Europe's largest and mos
 t import...
UID:ad5a1885-7d82-4c4e-9993-44136077de3b
END:VEVENT
END:VCALENDAR